Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SGNPDL-1V by Pfizer for Ovarian Cancer: Likelihood of Approval
SGNPDL-1V is under clinical development by Pfizer and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I...